Blake Aftab
Senior VP & Chief Scientific OfficerDr. Blake Aftab Ph.D., serves as Senior Vice President at Adicet Bio, Inc. since October 2021, and its Chief Scientific Officer since April 2021. He has served as Vice President and Head of Research since April 2021. Prior to Adicet, he was Vice President and Head of Preclinical Science and Translational Medicine at Atara Biotherapeutics, Inc., where he contributed to the company’s initial transition to cell therapy and led the focus on developing Allo-CAR T cell therapies. Previously, he led multiple research programs at University of California, San Francisco focused on drug discovery and clinical translation in multiple myeloma, including early research supporting targeted approaches for CD38, as well as other impactful targets of interest for CAR-T therapies. He received his Ph.D. from The Johns Hopkins University School of Medicine and holds a B.Sc. in Pharmacology and Drug Discovery, from The University of California, Santa Barbara.
公司职务
- 公司名称Adicet Bio, Inc.股票代码ACET职务Senior VP & Chief Scientific Officer共事同僚
- CSChen SchorCEO, President & Director
- LKLloyd KlicksteinInterim Chief Medical Officer & Director
- BNBrian Nicholas HarveyChief Financial Officer
- DHDonald HealeyChief Technology Officer
- JAJeffrey Allan ChodakewitzIndependent Director
- SDSteve DubinIndependent Director
- MJMichael J. GrissingerIndependent Director
